Dr. Daniel Schaft was awarded a doctorate from the University of Giessen for his biochemical and proteomic identification and analysis of native histone deacetylase and histone methyltransferase complexes at the European Molecular Biology Laboratory (EMBL) in Heidelberg and at the Biotechnology Center of the Technical University of Dresden (BIOTEC).

At the Victor Chang Cardiac Research Centre in Sydney, Dr. Schaft studied cardiac transcription factor complexes with relevance in congenital heart disease using cardiac stem cell models both as a post-doctoral fellow of the German Research Foundation (DFG) and of the Human Frontier Science Programs (HFSP).Having completed a Master of Intellectual Property Law at the University of Technology Sydney, and having qualified as an Australian and New Zealand Patent Attorney, Dr. Schaft worked at one of the largest Australian intellectual property law firms for many years. Having returned to Germany, at ULLRICH & NAUMANN in Heidelberg, Dr. Schaft continues to assist large corporate life science and pharmaceutical companies, small and medium-sized enterprises, biotech start-ups as well as individual inventors/entrepreneurs in protecting their intellectual property and in successfully bringing their inventions to the market.